AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9389919 — intervention group
Group type: EXPERIMENTAL
Intervention: 153Sm-EDTMP 1.0 mCi/kg
Number of subjects: 114
Study 9389919 — intervention group
Group type: EXPERIMENTAL
Intervention: 153Sm-EDTMP 0.5 mCi/kg
Number of subjects: 114
Study 9389919 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 114
Study 7525682 — intervention group
Group type: EXPERIMENTAL
Intervention: Inerpan (amino acid copolymer membrane)
Number of subjects: 168
Study 7525682 — intervention group
Group type: COMPARATOR
Intervention: Comfeel (hydrocolloid dressing)
Number of subjects: 168
Study 2448862 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation of the maxillary sinus (antroscopy and sinuscopy)
Number of subjects: 80
Study 2448862 — intervention group
Group type: COMPARATOR
Intervention: No irrigation of the maxillary sinus (control group)
Number of subjects: 80
Study 29032698 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery groups (Imagery 1 and Imagery 2)
Number of subjects: 0
Study 29032698 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 0
Study 28959813 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 varieties of cooked lentils (low GI values ranging from 10 to 23)
Number of subjects: 10
Study 25701170 — intervention group
Group type: EXPERIMENTAL
Intervention: Orteronel plus prednisone
Number of subjects: 1560
Study 25701170 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus prednisone
Number of subjects: 1560
Study 23697398 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 0
Study 23697398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20614859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (Ond) 24 mg QD
Number of subjects: 35
Study 20614859 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (Fl) 5 mg QD + Ondansetron (Ond) 12 mg QD
Number of subjects: 35
Study 20614859 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (Fl) 10 mg QD + Ondansetron (Ond) 24 mg QD
Number of subjects: 35
Study 20614859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 18787327 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular electroacupuncture (EA)
Number of subjects: 44
Study 18787327 — intervention group
Group type: COMPARATOR
Intervention: Autogenic training (AT)
Number of subjects: 44
Study 16669846 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ)
Number of subjects: 7
Study 16669846 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 7
Study 12797494 — intervention group
Group type: EXPERIMENTAL
Intervention: salmeterol (50 microg b.i.d.)
Number of subjects: 45
Study 12797494 — intervention group
Group type: COMPARATOR
Intervention: fluticasone (100 microg b.i.d.)
Number of subjects: 45
Study 11347856 — intervention group
Group type: EXPERIMENTAL
Intervention: lacidipine (4‐6 mg o.d.)
Number of subjects: 41
Study 11347856 — intervention group
Group type: EXPERIMENTAL
Intervention: hydrochlorothiazide (HCTZ) (25‐50 mg o.d.)
Number of subjects: 41
Study 11347856 — intervention group
Group type: COMPARATOR
Intervention: lacidipine and HCTZ
Number of subjects: 41
Study 8626951 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary urokinase 0.8 million U (group A)
Number of subjects: 60
Study 8626951 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary urokinase 1.6 million U (group B)
Number of subjects: 60
Study 8626951 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary urokinase 3.2 million U (group C)
Number of subjects: 60
Study 8626951 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving urokinase)
Number of subjects: 60
Study 1377074 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin therapy (2 x 10(6) kallikrein inhibitor units intravenous bolus after induction of anaesthesia followed by continuous infusion of 0.5 x 10(6) kallikrein inhibitor units/h until the end of the operation)
Number of subjects: 20
Study 1377074 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aprotinin therapy)
Number of subjects: 20
Study 6706301 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg per day of i.v. SAMe
Number of subjects: 18
Study 6706301 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg per day of i.v. SAMe
Number of subjects: 18
Study 6706301 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SAMe treatment)
Number of subjects: 18
Study 31113362 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified therapy based on mechanistic drivers and biomarkers of AF
Number of subjects: 0
Study 31113362 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction models developed for AF recurrence and AF-related outcomes
Number of subjects: 0
Study 31113362 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonised analysis of baseline and outcome data from 12 studies
Number of subjects: 0
Study 30061059 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation-absorbing surgical drapes
Number of subjects: 62
Study 30061059 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical draping
Number of subjects: 62
Study 27629780 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial competency training (PCT)
Number of subjects: 54
Study 27629780 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 54
Study 24438500 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (2 mSv)
Number of subjects: 3000
Study 24438500 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose computed tomography (8 mSv)
Number of subjects: 3000
Study 22935561 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B vaccination (HBV vaccination)
Number of subjects: 156
Study 19442378 — intervention group
Group type: EXPERIMENTAL
Intervention: Full vocal exercise protocol (FE)
Number of subjects: 40
Study 19442378 — intervention group
Group type: COMPARATOR
Intervention: Partial vocal exercise protocol (PE)
Number of subjects: 40
Study 17303766 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (4 individual, weekly sessions)
Number of subjects: 411
Study 17303766 — intervention group
Group type: COMPARATOR
Intervention: Usual stroke care
Number of subjects: 411
Study 15675575 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Number of subjects: 0
Study 15675575 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 0
Study 15675575 — intervention group
Group type: EXPERIMENTAL
Intervention: EGF receptor tyrosine kinase inhibitors (gefitinib and erlotinib)
Number of subjects: 0
Study 15457776 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid instrumentation (SCS)
Number of subjects: 30
Study 15457776 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic instrumentation (TWINFLEX)
Number of subjects: 30
Study 10422996 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist participation on medical rounds in the ICU
Number of subjects: 75
Study 10422996 — intervention group
Group type: COMPARATOR
Intervention: Control unit (no pharmacist participation)
Number of subjects: 75
Study 10422996 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist recommendations related to drug ordering
Number of subjects: 75
Study 8785381 — intervention group
Group type: EXPERIMENTAL
Intervention: Teasing protocol (sensory exposure to food) in humans
Number of subjects: 6
Study 8785381 — intervention group
Group type: COMPARATOR
Intervention: Fasting in humans
Number of subjects: 6
Study 8785381 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity teasing in dogs
Number of subjects: 6
Study 8785381 — intervention group
Group type: COMPARATOR
Intervention: Fasting in dogs
Number of subjects: 6
Study 8785381 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity teasing in dogs
Number of subjects: 6
Study 8785381 — intervention group
Group type: COMPARATOR
Intervention: Intragastric food protocol in dogs
Number of subjects: 6
Study 2206036 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg
Number of subjects: 8245
Study 2206036 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg
Number of subjects: 8245
Study 2206036 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg twice daily
Number of subjects: 8245
Study 2206036 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg twice daily
Number of subjects: 8245
Study 2206036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8245
Study 7399797 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical extract of Peganum harmala
Number of subjects: 0
Study 30507039 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastroenteric anastomosis
Number of subjects: 80
Study 30507039 — intervention group
Group type: COMPARATOR
Intervention: Billroth II gastroenteric anastomosis
Number of subjects: 80
Study 30507039 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall postoperative morbidity
Number of subjects: 80
Study 30507039 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality rate
Number of subjects: 80
Study 30507039 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaparotomy rate
Number of subjects: 80
Study 30507039 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of hospital stay
Number of subjects: 80
Study 26544563 — intervention group
Group type: EXPERIMENTAL
Intervention: femtosecond laser-assisted LASIK (femto-LASIK)
Number of subjects: 303
Study 26544563 — intervention group
Group type: EXPERIMENTAL
Intervention: epipolis LASIK (epi-LASIK)
Number of subjects: 303
Study 26544563 — intervention group
Group type: EXPERIMENTAL
Intervention: small incision lenticule extraction (SMILE)
Number of subjects: 303
Study 26544563 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SMILE, femto-LASIK, and epi-LASIK
Number of subjects: 303
Study 23415311 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 80 mg
Number of subjects: 486
Study 23415311 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone 160 mg
Number of subjects: 486
Study 23415311 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 600 mg
Number of subjects: 486
Study 23415311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 486
Study 21324043 — intervention group
Group type: EXPERIMENTAL
Intervention: Winograd surgery
Number of subjects: 100
Study 21324043 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve method
Number of subjects: 100
Study 19142107 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 501
Study 19142107 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 501
Study 17535232 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate and miconazole
Number of subjects: 35
Study 17535232 — intervention group
Group type: COMPARATOR
Intervention: Clobetasol propionate and placebo
Number of subjects: 35
Study 14764030 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrosonography
Number of subjects: 197
Study 14764030 — intervention group
Group type: COMPARATOR
Intervention: Transvaginal sonography
Number of subjects: 197
Study 11754119 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide drop formulation (50 mg x ml(‐1), Medley S/A Indústria Farmacêutica, Brazil)
Number of subjects: 24
Study 11754119 — intervention group
Group type: COMPARATOR
Intervention: Standard nimesulide drop formulation (Nisulid, 50 mg x ml(‐1), Astra Médica, Brazil)
Number of subjects: 24
Study 9532346 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 18
Study 9532346 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (Control)
Number of subjects: 18
Study 8033369 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (n = 38)
Number of subjects: 45
Study 8033369 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 16)
Number of subjects: 45
Study 8033369 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-menopausal women with loss greater than 3.5%/2 years
Number of subjects: 45
Study 8033369 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly osteopenic women (aged 68-72 years)
Number of subjects: 45
Study 2699786 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound Doppler device (group II)
Number of subjects: 0
Study 2699786 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time ultrasonograph (group III)
Number of subjects: 0
Study 2699786 — intervention group
Group type: COMPARATOR
Intervention: Anatomical landmarks (group I)
Number of subjects: 0
Study 2699786 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic aid (used in groups I and II for unsuccessful punctures)
Number of subjects: 0
Study 2699786 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound methods (group II and III)
Number of subjects: 0
Study 2699786 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound methods (group II)
Number of subjects: 0
Study 2699786 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocamera (compared with Doppler ultrasound)
Number of subjects: 0
Study 792665 — intervention group
Group type: EXPERIMENTAL
Intervention: Encephabol (pyritinol, pyrithioxine) administered orally, parenterally, and combined
Number of subjects: 317
Study 31018742 — intervention group
Group type: EXPERIMENTAL
Intervention: AS‐OCT imaging
Number of subjects: 50
Study 31018742 — intervention group
Group type: EXPERIMENTAL
Intervention: Slit lamp examination
Number of subjects: 50
Study 31018742 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheimpflug photography
Number of subjects: 50
Study 27393704 — intervention group
Group type: EXPERIMENTAL
Intervention: Holy Qur'an recitation (experimental group)
Number of subjects: 54
Study 27393704 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 54
Study 25546031 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 578
Study 25546031 — intervention group
Group type: COMPARATOR
Intervention: Fingolimod
Number of subjects: 578
Study 23459334 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine (RUP)
Number of subjects: 356
Study 23459334 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine (DES)
Number of subjects: 356
Study 23459334 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 356
Study 20952100 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin treatment (unfractionated heparin, low-molecular-weight heparin, or bivalirudin)
Number of subjects: 2632
Study 19243723 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT)
Number of subjects: 33
Study 19243723 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 33
Study 16696845 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical exerciser
Number of subjects: 272
Study 16696845 — intervention group
Group type: EXPERIMENTAL
Intervention: Active living target
Number of subjects: 272
Study 16696845 — intervention group
Group type: EXPERIMENTAL
Intervention: Excessive exerciser
Number of subjects: 272
Study 16696845 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-exerciser
Number of subjects: 272
Study 16696845 — intervention group
Group type: COMPARATOR
Intervention: Control target
Number of subjects: 272
Study 12631051 — intervention group
Group type: EXPERIMENTAL
Intervention: High SBP group (SBP ≥ 140 mmHg)
Number of subjects: 40
Study 12631051 — intervention group
Group type: COMPARATOR
Intervention: Normal SBP group (SBP < 140 mmHg)
Number of subjects: 40
Study 10671927 — intervention group
Group type: EXPERIMENTAL
Intervention: Current hypertension
Number of subjects: 5356
Study 10671927 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of antihypertensive medication
Number of subjects: 5356
Study 10671927 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 5356
Study 10671927 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 5356
Study 10671927 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 5356
Study 10671927 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 5356
Study 9062439 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast cancer questionnaire (BS)
Number of subjects: 0
Study 9062439 — intervention group
Group type: COMPARATOR
Intervention: Gynaecological cancer questionnaire (GS)
Number of subjects: 0
Study 8140382 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical vasoconstrictor pre-treatment
Number of subjects: 0
Study 8140382 — intervention group
Group type: COMPARATOR
Intervention: No vasoconstrictor pre-treatment (control)
Number of subjects: 0
Study 4030197 — intervention group
Group type: EXPERIMENTAL
Intervention: PPA 37.5 mg (therapeutic dose)
Number of subjects: 10
Study 4030197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30159620 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis (DBT)
Number of subjects: 14274
Study 30159620 — intervention group
Group type: COMPARATOR
Intervention: Digital mammography (DM)
Number of subjects: 14274
Study 30235903 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed messages
Number of subjects: 1353
Study 30235903 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed messages
Number of subjects: 1353
Study 30235903 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with high personal involvement
Number of subjects: 1353
Study 30235903 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants concerned about their health condition
Number of subjects: 1353
Study 30235903 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who suffered a food safety incident
Number of subjects: 1353
Study 25777061 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tsDCS (2 mA, 15 min)
Number of subjects: 10
Study 25777061 — intervention group
Group type: COMPARATOR
Intervention: Cathodal tsDCS (2 mA, 15 min)
Number of subjects: 10
Study 25777061 — intervention group
Group type: COMPARATOR
Intervention: Sham tsDCS (2 mA, 15 min)
Number of subjects: 10
Study 23478173 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Sensitization (IS)
Number of subjects: 1917
Study 23478173 — intervention group
Group type: COMPARATOR
Intervention: Insulin Provision (IP)
Number of subjects: 1917
Study 22909579 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental behavioral nutrition education to change to reduced-fat dairy foods
Number of subjects: 145
Study 22909579 — intervention group
Group type: COMPARATOR
Intervention: Reduce screen time (comparison control)
Number of subjects: 145
Study 20373130 — intervention group
Group type: EXPERIMENTAL
Intervention: Early abciximab administration before transfer to cathlab (group EA)
Number of subjects: 73
Study 20373130 — intervention group
Group type: COMPARATOR
Intervention: Late abciximab administration during PPCI (group LA)
Number of subjects: 73
Study 20373130 — intervention group
Group type: COMPARATOR
Intervention: Selective abciximab administration during PPCI (group SA)
Number of subjects: 73
Study 18508946 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy plus steroid pulse therapy (group C)
Number of subjects: 55
Study 18508946 — intervention group
Group type: COMPARATOR
Intervention: Steroid pulse monotherapy (group M)
Number of subjects: 55
Study 12370222 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis patients (n=13)
Number of subjects: 66
Study 12370222 — intervention group
Group type: EXPERIMENTAL
Intervention: RTX-CSA (n=13)
Number of subjects: 66
Study 12370222 — intervention group
Group type: EXPERIMENTAL
Intervention: RTX-FK (n=13)
Number of subjects: 66
Study 12370222 — intervention group
Group type: EXPERIMENTAL
Intervention: RTX-Phi (n=6)
Number of subjects: 66
Study 12370222 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (CON, n=15)
Number of subjects: 66
Study 12370222 — intervention group
Group type: EXPERIMENTAL
Intervention: RTX-NE (n=16)
Number of subjects: 66
Study 12370222 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis patients before and after RTX (n=4)
Number of subjects: 66
Study 12370222 — intervention group
Group type: EXPERIMENTAL
Intervention: RTX patients before and after nephrectomy (n=6)
Number of subjects: 66
Study 9839851 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline hyclate (DH)
Number of subjects: 1002
Study 9839851 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 1002
Study 7848489 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive GAPS Approach
Number of subjects: 200
Study 7848489 — intervention group
Group type: COMPARATOR
Intervention: Existing routines
Number of subjects: 200
Study 2647051 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstructive surgery
Number of subjects: 75
Study 2647051 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstructive surgery with subsequent physical training
Number of subjects: 75
Study 2647051 — intervention group
Group type: COMPARATOR
Intervention: Physical training alone
Number of subjects: 75
Study 31841078 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar Stabilization Treatment (LST)
Number of subjects: 52
Study 31841078 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Treatment (CFT)
Number of subjects: 52
Study 31841078 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 31267969 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-view digital breast tomosynthesis
Number of subjects: 182
Study 31267969 — intervention group
Group type: COMPARATOR
Intervention: Digital mammography
Number of subjects: 182
Study 28317885 — intervention group
Group type: EXPERIMENTAL
Intervention: Alginate-based reflux suppressant
Number of subjects: 100
Study 28317885 — intervention group
Group type: COMPARATOR
Intervention: Magnesium-aluminium antacid gel
Number of subjects: 100
Study 25111276 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention program for outpatient rehabilitation
Number of subjects: 85
Study 25111276 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study 25111276 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention program
Number of subjects: 85
Study 24791346 — intervention group
Group type: EXPERIMENTAL
Intervention: Permethrin 5% lotion applied twice with a one week interval
Number of subjects: 60
Study 24791346 — intervention group
Group type: COMPARATOR
Intervention: Single dose of oral ivermectin
Number of subjects: 60